US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 118.680
  • +1.890+1.62%
Trading Jan 22 13:39 ET
205.85BMarket Cap15.53P/E (TTM)

Abbott Laboratories Key Stats

Abbott Laboratories Q4 2024 Estimates Date

Currency:USDJan 22, 2025

Estimate YoY
Revenue
11.03B
+7.72%
EPS
1.05
+14.86%
Strong Buy

Jan 18, 2025

Abbott Laboratories Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 10.739B--
--2025/Q1-- / 10.282B--
Jan 22, 20252024/Q410.974B / 11.031B--
Oct 16, 20242024/Q310.635B / 10.551B--
Jul 18, 20242024/Q210.377B / 10.369B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 10.739B--
--2025/Q1-- / 10.282B--
Jan 22, 20252024/Q410.974B / 11.031B--
Oct 16, 20242024/Q310.635B / 10.551B--
Jul 18, 20242024/Q210.377B / 10.369B--

Unlock Free Earnings Estimates

Abbott Laboratories Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 18, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data